<DOC>
	<DOCNO>NCT02600741</DOCNO>
	<brief_summary>The primary purpose study evaluate overall effect caregiver receive study-provided caregiver psycho-education skill train program number treatment failure ( psychiatric hospitalization , psychiatric emergency room ( ER ) visit , crisis center visit , mobile crisis unit intervention , arrest/incarceration , suicide suicide attempt ) patient care 12 month period .</brief_summary>
	<brief_title>Family Intervention Recent Onset Schizophrenia Treatment ( FIRST )</brief_title>
	<detailed_description>This randomize , open-label , parallel group study patient schizophrenia , schizoaffective disorder , schizophreniform disorder caregiver . Study consist pair patient caregiver . Patients receive routine treatment , may include oral antipsychotic paliperidone palmitate , direct treat physician . Caregivers patient whose routine treatment paliperidone palmitate randomize receive either study-provided caregiver psycho-education skill train usual caregiver support . Caregivers patient whose routine treatment oral antipsychotic randomize Study Groups : Study Group 1 : Study-provided caregiver psycho-education skill training . Study Group 2 : Usual caregiver support ( caregiver support customarily provide study site , ) . Patients-caregiver pair follow 12 month follow baseline assessment . Cumulative number treatment failures 12 month assess primarily .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Perphenazine</mesh_term>
	<mesh_term>Fluphenazine</mesh_term>
	<mesh_term>Fluphenazine depot</mesh_term>
	<mesh_term>Fluphenazine enanthate</mesh_term>
	<mesh_term>Asenapine</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Prochlorperazine</mesh_term>
	<mesh_term>Loxapine</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Trifluoperazine</mesh_term>
	<mesh_term>Thiothixene</mesh_term>
	<mesh_term>Pimozide</mesh_term>
	<mesh_term>Thioridazine</mesh_term>
	<mesh_term>Droperidol</mesh_term>
	<mesh_term>Chlorpromazine</mesh_term>
	<criteria>A ) Caregivers Each caregiver must sign informed consent form ( ICF ) indicate understands purpose procedure require study willing participate duration study Caregiver able verbal interaction patient schizophrenia , schizoaffective disorder , schizophreniform disorder least twice week , per selfreport B ) Patients Patients must clinical diagnosis schizophrenia , schizoaffective disorder , schizophreniform disorder make clinician understanding Diagnostic Statistical Manual Mental Disorders ( DSM V ) criterion disorder Patients must receive ongoing psychiatric treatment study site must receive oral antipsychotic paliperidone palmitate long act therapy A ) Caregivers Caregiver mentally physically incapable adequately perform require study procedure , determine treatment team Caregiver receive structured manualized psychoeducation skill train within 1 year prior Screening B ) Patients Patient hospitalize ( medical psychiatric ) , incarcerate , otherwise institutionalized time randomization Patient consider significant potential imminent harm self and/or others base judgment treatment team Patient receive assertive community treatment ( ACT ) high intensity case management service prevent hospitalization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Caregiver</keyword>
	<keyword>Psycho-education skill train</keyword>
	<keyword>Paliperidone Palmitate</keyword>
	<keyword>Oral Antipsychotic</keyword>
</DOC>